FDA Approves First CBD Drug

In a watershed moment for the medicinal cannabis industry, the FDA has approved the very first medication derived from marijuana.

The drug is called Epidiolex. As CalMarijuanaPolicy discussed last week, this is a medication used to treat seizures associated with two severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And, the FDA is committed to this kind of careful scientific research and drug development,” said FDA Commissioner Scott Gottlieb, M.D. “Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients. Because of the adequate and well-controlled clinical studies that supported this approval, prescribers can have confidence in the drug’s uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes. We’ll continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and work with product developers who are interested in bringing patients safe and effective, high quality products. But, at the same time, we are prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims. Marketing unapproved products, with uncertain dosages and formulations can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”

Read the FDA’s press release here


Comments

Top Stories

Saturday, November 17, 2018 - 16:49

A large pot bust in Trinity County this month resulted in the seizure of over 900 marijuana plants and 5,069 pounds of untested cannabis ready to be sold on the black market.